DEVELOPMENT OF RECOMMENDATIONS FOR PHARMACISTS IN ACCORDANCE WITH GOOD PHARMACY PRACTICE FOR THE PREVENTION OF DIABETES MEASURE
DOI:
https://doi.org/10.32782/health-2025.2.11Keywords:
good pharmacy practice, diabetes, pharmacy, pharmacist, pharmaceutical services, pharmaceutical care, standard operating procedure, prevention, screeningAbstract
The article is devoted to the development of recommendations for the implementation of elements of the Good Pharmacy Practice (GPP) in pharmacies for the strategy implementation for the prevention of diabetes. Lifestyle changes, urbanization and changes in nutrition have contributed to the increase of patient’s number with diabetes, the main percentage of which have type 2 diabetes. Prevention is a powerful tool for reducing the risk of developing type 2 diabetes. In Ukraine the implementation and development of integrated strategies for the prevention of non- communicable diseases are unbalanced and insufficient, as evidenced by the tendency to increase the population with diabetes. Pharmacies are an integral part of the healthcare system, and involving pharmacists in the prevention of diabetes is productive, cost-effective for the healthcare system and can play a key role in reaching the population, especially in martial law. This accords the quality standards of pharmacy services “Good Pharmacy Practice”, up to which one of the practical areas of implementation is the educational activities of pharmacies and the identification of undiagnosed cases of the disease. To develop algorithms for the educational work of pharmacies, based on information search, elements of GPP for the prevention of diabetes were identified and a list of pharmacist interventions in the implementation of the strategy for the prevention of diabetes was formed, taking into account the national characteristics of the healthcare system with the definition of expected results. Content for the educational work of pharmacies about the prevention of diabetes in accordance with GPP was developed. Taking into account national priorities, an аlgorithm of pharmacist actions in implementing diabetes screening has been developed to identify individuals at risk among pharmacy visitors and provide them with appropriate recommendations. Recommended approaches for the prevention of diabetes have been formulated. The developed recommendations have a practical direction for implementation in practical pharmacy.
References
IDF Diabetes Atlas. 11th edition. International diabetes federation. 2025. 125 p.
Tomic D., Shaw J. E., Magliano D. J. The burden and risks of emerging complications of diabetes mellitus. Nat Rev Endocrinol. 2022. № 18. Р. 525–539. https://doi.org/10.1038/s41574-022-00690-7
Tuomilehto J., Lindström J., Eriksson J. G., Valle T. T., Hämäläinen H., Ilanne-Parikka P., Keinänen-Kiukaanniemi S. Prevention of Type 2 Diabetes Mellitus by Changes in Lifestyle among Subjects with Impaired Glucose Tolerance. N Engl J Med. 2001. № 344. Р. 1343–1350. https://doi.org/10.1056/NEJM200105033441801
World Health Organization. Sixty-Fifth World Health Assembly Resolutions, Decisions, Annexes. 2012 May 21–26. URL: http://www.who.int/mediacentre/events/2012/wha65/en/.WHA65/2012/REC/1
Resolution WHO 24 May 2021 Reducing the burden of noncommunicable diseases through strengthening prevention and control of diabetes. URL: https://apps.who.int/gb/ebwha/pdf_files/WHA74/A74_ACONF5-en.pdf
Tuomilehto J., Uusitupa M., Gregg E. W., Lindström J. Type 2 Diabetes Prevention Programs – From Proof-of-Concept Trials to National Intervention and Beyond. Journal of Clinical Medicine. 2023. № 12(5). Р. 1876. https://doi.org/10.3390/jcm12051876
Galaviz K. I., Narayan K. M. V., Lobelo F., Weber M. B. Lifestyle and the prevention of type 2 diabetes: a status report. Am J Lifestyle Med. 2015. № 12(1). Р. 4–20. https://doi.org/10.1177/1559827615619159
Li R., Qu S., Zhang P., Chattopadhyay S., Gregg E. W., Albright A., Hopkins D., Pronk N. P. Economic Evaluation of Combined Diet and Physical Activity Promotion Programs to Prevent Type 2 Diabetes Among Persons at Increased Risk: A Systematic Review for the Community Preventive Services Task Force. Ann Intern Med. 2015. № 163(6). Р. 452–460. https://doi.org/10.7326/M15-0469
Benedict A., Spence M., Sie J., Chin H., Ngo C., Salmingo J., Vidaurreta A., Rashid N. Evaluation of a pharmacist-managed diabetes program in a primary care setting within an integrated health care system. J Manag Care Spec Pharm. 2018. № 2. Р. 114–122. https://doi.org/10.18553/jmcp.2018.24.2.114
Tackling NCDs: “Best buys” and other recommended interventions for the prevention and control of noncommunicable disease. Geneva : World Health Organization. 2017. 25 р.
Joint FIP/WHO Guidelines on Good Pharmacy Practice (GPP): Standards for Quality of Pharmacy Services. WHO Technical Report Series, 2011. No. 961. Р. 310–323. URL: http://apps.who.int/medicinedocs/en
Rx for the National Diabetes Prevention Program: Action Guide for Community Pharmacists. Atlanta, GA : Centers for Disease Control and Prevention, US Dept of Health and Human Services. 2019. 24 р.
Haw J. S., Galaviz K. I., Straus A. N., Kowalski A. J., Magee M. J., Weber M. B., Wei J., Narayan K. M. V., Ali M. K. Long-term Sustainability of Diabetes Prevention Approaches: A Systematic Review and Meta-analysis of Randomized Clinical Trials. JAMA Intern Med. 2017. № 177(12). Р. 1808–1817. https://doi.org/10.1001/jamainternmed.2017.6040
Власенко І. О., Давтян Л. Л. Стандарти належної аптечної практики як базис реалізації концепції фармацевтичної допомоги пацієнтам з цукровим діабетом. Фармацевтичний часопис. 2022. № 1. С. 74–82. https://doi.org/10.11603/2312- 0967.2022.1.13058
Wang Z., Liu D., Zhao Y., Li M., Bai Y., Mi S., Liang X., Zhao W. Recommendations and future direction for population-based prevention and control of behavioral risk factors for NCDs. China CDC Wkly. 2022. № 4(19). Р. 407–410. https://doi.org/10.46234/ccdcw2022.092
American Diabetes Association. Prevention or Delay of Type 2 Diabetes: Standards of Medical Care in Diabetes. Diabetes Care. 2021. № 44(1). Р. 34–39. https://doi.org/10.2337/dc21-S003
Rhee J. J., Mattei J., Hughes M. D., Hu F. B., Willett W.C. Dietary diabetes risk reduction score, race and ethnicity, and risk of type 2 diabetes in women. Diabetes Care. 2015. № 38(4). Р. 596–603. https://doi.org/10.2337/dc14-1986
Awika J. M., Rose D. J., Simsek S. Complementary effects of cereal and pulse polyphenols and dietary fiber on chronic inflammation and gut health. Food Funct. 2018. № 9(3). Р. 1389–1409. https://doi.org/10.1039/c7fo02011b
Luo X., Sui J., Yang W., Sun Q., Ma Y., Simon T. G., Liang G., Meyerhardt J. A., Chan A. T., Giovannucci E. L., Zhang X. Type 2 Diabetes Prevention Diet and Hepatocellular Carcinoma Risk in US Men and Women. Am J Gastroenterol. 2019. № 114(12). Р. 1870–1877. https://doi.org/10.14309/ajg.0000000000000450
Kang J. H., Peng C., Rhee J. J., Farvid M. S., Willett W. C., Hu F. B., Rosner B. A., Tamimi R., Eliassen A. H. Prospective study of a diabetes risk reduction diet and the risk of breast cancer. Am J Clin Nutr. 2020. № 112(6). Р. 1492–1503. https://doi.org/10.1093/ajcn/nqaa268
Huang Y., Liu F., Chen A. M., Yang P. F., Peng Y., Gong J. P., Li Z., Zhong G. C. Type 2 diabetes prevention diet and the risk of pancreatic cancer: A large prospective multicenter study. Clin Nutr. 2021. № 40(11). Р. 5595–5604. https://doi.org/10.1016/j.clnu.2021.09.037
Kremer D. Red meat and type 2 diabetes: do methodological advancements sufficiently increase the certainty of evidence. The American journal of clinical nutrition. 2023. № 118(6). Р. 1075–1076. https://doi.org/10.1016/j.ajcnut.2023.09.022
Maryniuk M. D. From pyramids to plates to patterns: perspectives on meal planning. Diabetes Spectr. 2017. № 30(2). Р. 67–70. https://doi.org/10.2337/ds16-0080
Wang C.-R., Hu T.-Y., Hao F.-B., Chen N., Peng Y., Wu J.-J., Yang P.-F. Zhong G.-C. Type 2 Diabetes – Prevention Diet and All-Cause and Cause-Specific Mortality: A Prospective Study. American Journal of Epidemiology. 2022. № 191(3). Р. 472–486. https://doi.org/10.1093/aje/kwab265
Коритнюк Р. С., Давтян Л. Л., Гудзь Н. І., Дроздова А. О., Власенко І. О., Лелека М. В., Оліфірова Т. Ф. Медико-біологічна функція води. Фармацевтичний журнал. 2019. № 3. Р. 65–75. https://doi.org/10.32352/0367-3057.3.19.08
Logan-Sprenger H. M., Heigenhauser G. J., Jones G. L., Spriet L. L. The effect of dehydration on muscle metabolism and time trial performance during prolonged cycling in males. Physiol Rep. 2015. № 3(8). Р. 12483. https://doi.org/10.14814/phy2.12483
Shaheen N. A., Alqahtani A. A., Assiri H., Alkhodair R., Hussein M. A. Public knowledge of dehydration and fluid intake practices: variation by participants’ characteristics. BMC Public Health. 2018. № 18(1). Р. 1346. https://doi.org/10.1186/s12889-018-6252- 5
Bao Y., Tu X., Wei Q. Water for preventing urinary stones. Cochrane Database of systematic Rewievs. 2012. № 6. Art CD004292. https://doi.org/10.1002/14651858.CD004292.pub4
Vij V. A., Joshi A. S. Effect of ‘water induced thermogenesis’ on body weight, body mass index and body composition of overweight subjects. J Clin Diagn Res. 2013. № 7(9). Р. 1894–1896. https://doi.org/10.7860/JCDR/2013/5862.3344
Van Walleghen E. L., Orr J., Chris L., Gentile C. L., Davy B. M. Pre-meal water consumption reduces meal energy intake in older but not younger subjects. Obesity. 2007. № 15(1). Р. 93–99. https://doi.org/10.1038/oby.2007.506
Afrisham R., Paknejad M., Soliemanifar O., Sadegh-Nejadi S., Meshkani R., Ashtary-Larky D. The influence of psychological stress on the initiation and progression of diabetes and cancer. Int J Endocrinol Metab. 2019. № 17(2). Р. e67400. https://doi.org/10.5812/ijem.67400
Maddatu J., Anderson-Baucum E., Evans-Molina C. Smoking and the risk of type 2 diabetes. Transl Res. 2017. № 184. Р. 101–107. https://doi.org/10.1016/j.trsl.2017.02.004
Register S. J., Harrington K. F., Agne A. A., Cherrington A. L. Effectiveness of nonprimary care-based smoking cessation interventions for adults with diabetes: a systematic literature review. Curr Diab Rep. 2016. № 16(9). Art81. https://doi.org/10.1007/s11892-016-0777-8
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Ірина Олексіївна Власенко
This work is licensed under a Creative Commons Attribution 4.0 International License.
